CXXI Stock Overview
An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
C21 Investments Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.28 |
| 52 Week High | CA$0.64 |
| 52 Week Low | CA$0.20 |
| Beta | 2.27 |
| 1 Month Change | -5.17% |
| 3 Month Change | -8.33% |
| 1 Year Change | -50.00% |
| 3 Year Change | -51.75% |
| 5 Year Change | -47.12% |
| Change since IPO | -98.90% |
Recent News & Updates
Some C21 Investments Inc. (CSE:CXXI) Shareholders Look For Exit As Shares Take 26% Pounding
Nov 12
Subdued Growth No Barrier To C21 Investments Inc.'s (CSE:CXXI) Price
Sep 12Recent updates
Some C21 Investments Inc. (CSE:CXXI) Shareholders Look For Exit As Shares Take 26% Pounding
Nov 12Subdued Growth No Barrier To C21 Investments Inc.'s (CSE:CXXI) Price
Sep 12C21 Investments Inc.'s (CSE:CXXI) 30% Share Price Surge Not Quite Adding Up
May 12A Look At The Intrinsic Value Of C21 Investments Inc. (CSE:CXXI)
May 01Some Confidence Is Lacking In C21 Investments Inc. (CSE:CXXI) As Shares Slide 27%
Mar 09Is C21 Investments (CSE:CXXI) A Risky Investment?
Sep 04These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well
Mar 21These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well
Nov 29C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Oct 12A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)
Apr 22Does C21 Investments (CSE:CXXI) Have A Healthy Balance Sheet?
Mar 22C21 Investments' (CSE:CXXI) Solid Earnings May Rest On Weak Foundations
Oct 05We Think C21 Investments (CSE:CXXI) Can Stay On Top Of Its Debt
Sep 03C21 Investments (CSE:CXXI) Seems To Use Debt Quite Sensibly
Mar 07Shareholder Returns
| CXXI | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -5.2% | -2.5% | -0.5% |
| 1Y | -50.0% | -52.4% | 17.7% |
Return vs Industry: CXXI matched the Canadian Pharmaceuticals industry which returned -49.3% over the past year.
Return vs Market: CXXI underperformed the Canadian Market which returned 17.9% over the past year.
Price Volatility
| CXXI volatility | |
|---|---|
| CXXI Average Weekly Movement | 19.1% |
| Pharmaceuticals Industry Average Movement | 12.8% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CXXI's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: CXXI's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 114 | Sonny Newman | www.cxxi.ca |
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk, wholesale, and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services.
C21 Investments Inc. Fundamentals Summary
| CXXI fundamental statistics | |
|---|---|
| Market cap | CA$33.61m |
| Earnings (TTM) | -CA$448.66k |
| Revenue (TTM) | CA$38.94m |
0.8x
P/S Ratio-73.6x
P/E RatioIs CXXI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CXXI income statement (TTM) | |
|---|---|
| Revenue | US$26.79m |
| Cost of Revenue | US$17.58m |
| Gross Profit | US$9.21m |
| Other Expenses | US$9.52m |
| Earnings | -US$308.63k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0026 |
| Gross Margin | 34.38% |
| Net Profit Margin | -1.15% |
| Debt/Equity Ratio | 3.7% |
How did CXXI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 12:04 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
C21 Investments Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|